Transcriptional anti-angiogenesis therapy of human pancreatic cancer

Cytokine & Growth Factor Reviews
Keping XieSuyun Huang

Abstract

Pancreatic cancer angiogenesis has been attributed to genetic and epigenetic alterations (e.g., oncogene activation and suppressor inactivation) and a chaotic tumor microenvironment (e.g., hypoxia, acidosis, free radical stress and imbalanced growth factor production). Those diverse "upstream signal" factors appear to converge their signaling pathways on limited sets of nuclear transcription factors (e.g., Sp1, Stat3 and NF-kappaB). Aberrant activities of these factors confer a tremendous survival and growth advantage to existing and/or emerging malignant cells through alteration of the expression and functions of their diverse "downstream effector" factors (e.g., VEGF and IL-8). Therefore, targeting a single transcription factor can affect the malignant phenotype more profoundly than just targeting any single upstream signal and/or downstream effector factor.

Citations

Jan 23, 2008·Langenbeck's Archives of Surgery·Chery Whipple, Murray Korc
Jun 22, 2010·TheScientificWorldJournal·Patrick ChamesDaniel Baty
May 30, 2014·Drug Design, Development and Therapy·Chengyuan QianDong Wang
Feb 1, 2011·Journal of Gastrointestinal Cancer·Volker Ellenrieder, Martin E Fernandez-Zapico
Mar 14, 2007·Scandinavian Journal of Gastroenterology·Ursula AhoRoland Andersson
Feb 11, 2016·Seminars in Cell & Developmental Biology·Teresa A ZimmersAndrea Bonetto
Feb 22, 2012·Cytokine & Growth Factor Reviews·Chen Huang, Keping Xie
Feb 16, 2010·Biochemical and Biophysical Research Communications·Mia C DeFinoChris Hague
Jan 30, 2015·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Mi-die XuXiang Du
Nov 26, 2008·Cancer Treatment Reviews·Ghassan El MaaloufEric Raymond
Aug 23, 2008·American Journal of Surgery·Daniel Borja-CachoSelwyn Maurice Vickers
Nov 26, 2010·The Mount Sinai Journal of Medicine, New York·Soley Bayraktar, Caio M Rocha-Lima
Jan 15, 2014·Biochimica Et Biophysica Acta·Chen HuangKeping Xie
Feb 22, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Mei ZhaoBin Jiang
Jun 27, 2015·Genes & Diseases·Dacheng Xie, Keping Xie
Dec 22, 2009·Integrative Biology : Quantitative Biosciences From Nano to Macro·Christine P TanClaudia Fischbach
May 19, 2016·Oncotarget·Ran CuiXiang-Lin Tan
Mar 21, 2019·Cancers·Tiziana AnneseDomenico Ribatti
Nov 7, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Masashi KanaiKeping Xie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Related Papers

The New England Journal of Medicine
William R BruggeAndrew L Warshaw
Advances in Anatomic Pathology
Anirban MaitraRalph H Hruban
Langenbeck's Archives of Surgery
Chery Whipple, Murray Korc
© 2021 Meta ULC. All rights reserved